Upstate Active Clinical Trials
Study Title:A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naïve HIV-1 infected adolescents and children aged ≥6 to <18 years
What is the purpose of the study? (in Layman's terms, please describe the study)Doctor Leonard B Weiner, MD is doing this study for the sponsor. An independent ethics committee or institutional review board has approved the study.
Research studies are done to find out the best way to treat patients. Research studies may test drugs or other types of treatments.
Upstate Institutional Review Board (IRB) Number:831029
Study Phase:Phase II
Patient Age Group:Children
Principal Investigator:Leonard B Weiner
Who can I contact for more information?
Name: Wendy A Holz